二维及彩色多普勒超声诊断桥本甲状腺炎  

Two-dimensional and color Doppler ultrasonographic diagnosis of Hashimoto thyroiditis

作　　者：邵玉红[1] 倪海英[1] 邹英华[2] 

机构地区：[1]北京大学第一医院超声科,北京100034 [2]北京大学第一医院介入血管外科,北京100034

出　　处：《中国介入影像与治疗学》2010年第2期157-160,共4页Chinese Journal of Interventional Imaging and Therapy

摘　　要：目的评价二维及彩色多普勒超声对桥本甲状腺炎(HT)的诊断价值。方法收集确诊为HT的患者65例(病例组)行甲状腺超声检查,另选取60名甲状腺正常者作为对照组,记录甲状腺的大小、回声、甲状腺实质的血流分布状况、伴发结节情况、甲状腺上动脉血流参数、病理改变和临床化验指标等。结果病例组甲状腺体积明显大于对照组(t=10.748,P<0.001),甲状腺回声不同程度弥漫性对称减低(51/65,78.46%),甲状腺内弥漫分布线样强回声(46/65,70.77%),单发或多发桥本结节(6/65,9.23%);彩色多普勒血流显像(CDFI)表现为血流明显增加(36/65,55.38%)、血流轻度增加(25/65,38.46%)、血流减少或未见明显变化(4/65,6.15%)。3种现象间的T3、T4、TSH、Vmax差异有统计学意义(P<0.001)。结论HT的二维超声影像、CDFI表现、临床生化及病理表现关系密切,超声对于HT的诊断及鉴别诊断具有较高的价值。Objective To assess the value of two-dimensional and color Doppler ultrasonography in diagnosis of Hashimoto thyroiditis（HT）.Methods Sixty-five patients with HT（HT group） confirmed histologically underwent two-dimensional and color Doppler ultrasonography.Sixty volunteers with normal thyroid ultrasonogram were enrolled as control group.Ultrasonic characteristics（size,echo,blood flow distribution,peak systolic velocity of the superior thyroid artery,accompanied nodules）,pathological finding and laboratory parameters were recorded.Results The volume of thyroid increased in HT group than that of control group（t=10.748,P〈0.001）.Ultrasonic characteristics of HT were as followed： hypoechoic parenchyma（51/65,78.46%）,multiple liner bright echoes throughout the parenchyma（46/65,70.77%）,single or multiple macronodules in the parenchyma（6/65,9.23%）.Color Doppler flow imaging（CDFI） showed obviously increased blood flow（36/65,55.38%）,slightly increased blood flow（25/65,38.46%）,decreased or normal blood flow（4/65,6.15%）,among which statistical differences of T3,T4,TSH,Vmax were detected（P〈0.001）.Conclusion There is close relationship among ultrasonic characteristics,pathological and laboratory parameters of HT.Ultrasonography has high value in diagnosis and differential diagnosis of HT.

关 键 词：甲状腺炎 超声检查 病理学 

分 类 号：R581.4[医药卫生—内分泌] R445.1[医药卫生—内科学]